Jones Financial Companies Lllp boosted its position in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 14.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 336,958 shares of the pharmacy operator’s stock after buying an additional 43,621 shares during the period. Jones Financial Companies Lllp’s holdings in CVS Health were worth $25,530,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the company. Avion Wealth boosted its stake in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the period. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares during the last quarter. Corundum Trust Company INC acquired a new stake in shares of CVS Health during the third quarter worth about $29,000. Harbor Asset Planning Inc. purchased a new position in shares of CVS Health during the second quarter worth about $30,000. Finally, Front Row Advisors LLC increased its position in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have weighed in on CVS shares. Wolfe Research lifted their target price on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. JPMorgan Chase & Co. upped their price objective on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Truist Financial set a $100.00 target price on shares of CVS Health in a report on Wednesday, December 10th. Finally, The Goldman Sachs Group raised their price objective on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $94.82.
CVS Health Price Performance
CVS stock opened at $76.80 on Wednesday. The firm has a 50 day moving average of $78.82 and a 200-day moving average of $75.43. The company has a market cap of $97.49 billion, a price-to-earnings ratio of 202.11, a PEG ratio of 0.69 and a beta of 0.50. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12-month low of $53.36 and a 12-month high of $85.15.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s dividend payout ratio is 700.00%.
CVS Health Company Profile
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Stories
- Five stocks we like better than CVS Health
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- 1 Hour Once A Day
- [No Brainer Gold Play]: “Show me a better investment.”
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
